Teligent, Inc. (TLGT) News
Filter TLGT News Items
TLGT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TLGT News Highlights
- For TLGT, its 30 day story count is now at 3.
- Over the past 1 day, the trend for TLGT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- ABVC and LMFA are the most mentioned tickers in articles about TLGT.
Latest TLGT News From Around the Web
Below are the latest news stories about Teligent Inc that investors may wish to consider to help them evaluate TLGT as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning! |
22 Stocks Moving in Friday's Pre-Market SessionGainers LM Funding America, Inc. (NASDAQ: LMFA) rose 39.5% to $4.80 in pre-market trading after declining around 15% on Thursday. The company recently announced it purchased an additional 4,000 S19J Pro Antminer Machines for a price of $25.3 million to further expand the company's mining capabilities. ABVC BioPharma, Inc. (NASDAQ: ABVC) rose 24.4% to $3.06 in pre-market trading after gaining around 5% on Thursday. ABVC BioPharma recently restructured its joint venture with Lucida. Avadel Pharmac |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayGood morning, investor! |
Generic drug maker Teligent files for bankruptcy protection, explores sale of the companySouth Jersey specialty generic pharmaceutical firm Teligent Inc. filed for voluntarily bankruptcy protection on Thursday as it pursues the sale of the company or its core assets. Teligent Inc. of Buena in Atlantic County also said it is arranging for $12 million debtor-in-possession financing from its senior secured lenders. The company also announced that CEO Tim Sawyer and Philip Yachmetz, Teligent's chief legal officer and executive vice president, resigned effective Oct. 8. |
Teligent to Pursue Asset Sale through Voluntary Chapter 11 ProcessTeligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company ("Teligent" or the "Company"), today announced that the Company has, together with certain of its affiliates, filed for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to pursue a sale process that is intended to maximize the value of the Company. |
Thinking about buying stock in SOS Ltd, VICI Properties, Gevo, Up Fintech, or Teligent?NEW YORK , Sept. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SOS, VICI, GEVO, TIGR, and TLGT. Full story available on Benzinga.com |
Global Lidocaine Ointment Market Growth Analysis, Latest Trends and Forecast till 2027| AstraZeneca Plc, Glenmark Pharmaceuticals, Teligent IncThe report provides an in-depth analysis of the global lidocaine ointment market, including current trends and forecasts to help investors identify potential investment opportunities. The report includes a detailed analysis of the market''s driving and limiting forces. Lidocaine ointment is |
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update–Update on FDA Inspection of Buena Facility–Assessing New Growth Opportunities in Injectables–Conference Call to Be Held on August 16, 2021 at 8:30 am Eastern Standard Time –Dial in: (877) 407-0792 US Toll Free Number (201) 689-8263 International Number Confirmation Number: 13721972 BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a bu |
Teligent, Inc. to Hold Conference Call for Second Quarter 2021 Financial Results on Monday, August 16, 2021BUENA, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Monday, August 16th, 2021 to discuss the second quarter ended June 30, 2021 financial results and business update. Conference Call InformationDate: Monday, August 16, 2021Time: 8:30 a.m. Eastern TimeDial-in numbers: Toll Free: 877-407-0792 International: 201-689-8263Confere |
Teligent, Inc. Announces Adjournment of Annual Meeting of StockholdersScheduled to Reconvene on July 21, 2021Company Urgently Encourages Stockholders to Vote BUENA, N.J., June 30, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), a New Jersey-based specialty generic pharmaceutical company (the “Company”), announced today that its Annual Meeting of Stockholders, scheduled for June 18, 2021 and adjourned to June 30, 2021, was convened and adjourned without any business being conducted due to the fact that there were not sufficient votes to approve all of the p |